ARQ 736

ARQ-736 · ArQule, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ 736, covering 2013-05-03 to 2013-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations [Phase 1]

See pricing